Table 3 |
||||||
|
Prediction of persistent synovitis, DMARD prescription and RA in final multivariate logistic regression models |
||||||
|
Dependent variable |
||||||
|
|
||||||
|
Persistent synovitis n = 98 |
DMARD start n = 106 |
RA n = 68 |
||||
|
|
||||||
|
Baseline variables |
OR (95% CI) |
P value |
OR (95% CI) |
P value |
OR (95% CI) |
P value |
|
|
||||||
|
Age (years) |
1.01 (0.99-1.03) |
0.18 |
1.00 (0.98-1.02) |
0.70 |
1.04 (1.01-1.08) |
0.018 |
|
Female gender |
1.20 (0.68-2.12) |
0.52 |
0.99 (0.54-1.79) |
0.97 |
1.24 (0.51-3.01) |
0.64 |
|
ACPA positivity |
4.50 (2.17-9.33) |
< 0.001 |
8.11 (3.55-18.6) |
< 0.001 |
19.3 (6.84-54.4) |
< 0.001 |
|
IgM RF positivity |
- |
- |
- |
- |
5.02 (1.47-17.1) |
0.010 |
|
Small joint arthritis§ |
2.11 (1.17-3.81) |
0.013 |
3.86 (2.02-7.37) |
< 0.001 |
3.45 (1.21-9.90) |
0.021 |
|
HAQ |
1.73 (1.12-2.68) |
0.014 |
1.75 (1.13-2.74) |
0.012 |
- |
- |
|
28-TJC |
- |
- |
1.06 (1.00-1.13) |
0.064 |
1.09 (1.02-1.16) |
0.012 |
|
CRP (mg/l) |
0.99 (0.98-1.00) |
0.042 |
- |
- |
- |
- |
|
Constant |
0.069 |
- |
0.075 |
- |
0.003 |
- |
|
|
||||||
|
§ Metacarpo-phalangeal joint, proximal interphalangeal joint, or metatarso-phalangeal joint joint swelling. ACPA = anti-citrullinated protein antibody; CI = confidence interval; CRP = C-reactive protein; DMARD = disease-modifying anti-rheumatic drugs; HAQ = Health Assessment Questionnaire; OR = odds ratio; RA = rheumatoid arthritis; RF = rheumatoid factor; TJC = tender joint count. |
||||||
|
Mjaavatten et al. Arthritis Research & Therapy 2009 11:R146 doi:10.1186/ar2820 |
||||||